Open AccessClinical Outcomes of Transplanted Modified Bone Marrow–Derived Mesenchymal Stem Cells in Stroke
Author(s) -
Gary K. Steinberg,
Douglas Kondziolka,
Lawrence R. Wechsler,
L. Dade Lunsford,
Maria Coburn,
Julia Billigen,
Anthony Kim,
Jeremiah N. Johnson,
Damien Bates,
Bill King,
Casey Case,
Michael McGrogan,
Ernest W. Yankee,
Neil Schwartz
Publication year - 2016
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.116.012995
Subject(s) - medicine , mesenchymal stem cell , bone marrow , stroke (engine) , stem cell , stroke recovery , pathology , microbiology and biotechnology , physical therapy , mechanical engineering , engineering , rehabilitation , biology
Preclinical data suggest that cell-based therapies have the potential to improve stroke outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom